SPTBN1 has recently been assigned a role as a therapeutic target for nonalcoholic steatohepatitis and liver cancer and thus detecting further highly expressed transcripts of this gene is important. This evidence concerns the gene SPTBN1 and metabolic dysfunction-associated steatohepatitis.